Similar articles

• The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.

  Spiegel BM, Targownik L, Dulai GS, Gralnek IM. Spiegel BM, et al. Ann Intern Med. 2003 May 20;138(10):795-806. doi: 10.7326/0003-4819-138-10-200305200-00007. Ann Intern Med. 2003. PMID: 12755551
• COX-2 inhibitors. Magic bullets or merely mortal?

  [No authors listed] [No authors listed] Harv Health Lett. 2000 Feb;25(4):4. Harv Health Lett. 2000. PMID: 10637015 No abstract available.
• The cox-2 inhibitors.

  Strassels S. Strassels S. J Mass Dent Soc. 1999 Fall;48(3):43-4. J Mass Dent Soc. 1999. PMID: 10808349 No abstract available.
• Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

  Jüni P, Rutjes AW, Dieppe PA. Jüni P, et al. BMJ. 2002 Jun 1;324(7349):1287-8. doi: 10.1136/bmj.324.7349.1287. BMJ. 2002. PMID: 12039807 Free PMC article. No abstract available.
• [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].

  Oliw E, Wollheim FA. Oliw E, et al. Lakartidningen. 2000 Jun 14;97(24):2942-4. Lakartidningen. 2000. PMID: 10900877 Review. Swedish. No abstract available.